當(dāng)前位置：首頁 > 資料下載 > ipatherapeutics 2026年終端采購售價(jià)清單-上海起發(fā)

ipatherapeutics 2026年終端采購售價(jià)清單-上海起發(fā)

發(fā)布時(shí)間：2025/12/19 點(diǎn)擊次數(shù)：306

荷蘭ipatherapeutics生物公司是ImmunoPrecise Antibodies Ltd.（NASDAQ: IPA）旗下的重要品牌，是一家在生物治療領(lǐng)域具有影響力的合同研究組織。公司成立于1989年，總部位于美國法戈，并在北美和歐洲設(shè)有多個(gè)分支機(jī)構(gòu)，員工規(guī)模在51至200人之間。該公司專注于抗體發(fā)現(xiàn)與開發(fā)服務(wù)，致力于通過融合生物技術(shù)和人工智能技術(shù)推動生物治療創(chuàng)新。

ipatherapeutics的核心技術(shù)平臺包括其獨(dú)特的B細(xì)胞選擇®兔單克隆抗體技術(shù)、轉(zhuǎn)基因動物模型以及多通道膜蛋白靶向抗體平臺。兔免疫系統(tǒng)的優(yōu)勢在于能產(chǎn)生高特異性和高親和力抗體，結(jié)合公司功能優(yōu)先的B細(xì)胞選擇工作流程，可在早期識別出優(yōu)秀的診斷抗體面板。其轉(zhuǎn)基因動物模型能夠針對小于3 kDa的小分子和具有復(fù)雜二級結(jié)構(gòu)的蛋白質(zhì)生成大量序列多樣、生物學(xué)相關(guān)的候選抗體。在多通道膜蛋白靶向抗體方面，公司通過BLI平臺進(jìn)行特異性測試，結(jié)合抗體面板的親和力排名或表位映射和分箱，實(shí)現(xiàn)分子質(zhì)量優(yōu)化。

公司近年來積極整合人工智能技術(shù)，特別是其LENSai™計(jì)算軟件平臺和HYFT技術(shù)，通過多組學(xué)建模和復(fù)雜的人工智能系統(tǒng)支持抗體發(fā)現(xiàn)過程。2023年，公司通過收購BioStrand獲得了一套基于云的革命性解決方案，能夠加速多組學(xué)研究數(shù)據(jù)分析。此外，公司的OmniChicken®發(fā)現(xiàn)平臺是行業(yè)內(nèi)成功改造的鳥類平臺，具有能夠產(chǎn)生人類序列抗體庫的免疫系統(tǒng)。

ipatherapeutics提供抗體開發(fā)服務(wù)，涵蓋從定制單克隆和多克隆抗體開發(fā)、抗體工程與優(yōu)化到抗體生產(chǎn)和純化的完整流程。公司服務(wù)對象包括制藥公司、生物技術(shù)企業(yè)、研究機(jī)構(gòu)和學(xué)術(shù)界客戶。其產(chǎn)品線涵蓋多種研究用抗體，包括針對各種疾病靶點(diǎn)的單克隆抗體，例如貨號MQ13.101的鼠標(biāo)抗瓜氨酸纖維蛋白原抗體和貨號MQR2.201的人抗凋亡 cleavage product of human U1-70K抗體等。

公司將自身定位為“生物治療智能的中心"，通過結(jié)合專業(yè)知識和技術(shù)，為制藥合作伙伴提供高度專業(yè)化的全連續(xù)治療性抗體發(fā)現(xiàn)、開發(fā)和對外許可服務(wù)。公司的使命是為制藥客戶提供智能和技術(shù)來治療疾病，目標(biāo)是提高生物治療的特異性。

關(guān)鍵詞：ipatherapeutics，ipatherapeutics上海代理，ipatherapeutics中國代理，ipatherapeutics北京代理，ipatherapeutics江蘇代理， ipatherapeutics廣東代理,N002-100ML, N001-0.5mg, N001-0.1mg, R001-100ML, L101-0.025mg immunoprecise u-proteinexpress、ipatherapeutics、免疫精確抗體、IPA生物治療、B細(xì)胞選擇兔單克隆抗體、人工智能抗體發(fā)現(xiàn)、LENSai平臺、OmniChicken技術(shù)、轉(zhuǎn)基因動物模型、多通道膜蛋白靶向、抗體發(fā)現(xiàn)服務(wù)、生物治療智能、定制抗體開發(fā)、HYFT技術(shù)、治療性抗體、生物制藥研發(fā)、GPCR抗體、結(jié)構(gòu)生物學(xué)、抗體人源化、生物標(biāo)記物發(fā)現(xiàn)、臨床前開發(fā)。

特別告知：為保證產(chǎn)品質(zhì)量與良好性能，所以在購買相應(yīng)產(chǎn)品的同時(shí)我司會收取一定量的運(yùn)輸費(fèi)用！！！本次報(bào)價(jià)有效時(shí)間為2025年12月19日---2026年12月20日。

（*此為部分產(chǎn)品價(jià)格,完整價(jià)格請下載文件)

貨號	品名	規(guī)格	價(jià)格	品牌
N001-0.1 mg	WNT Surrogate-Fc Fusion Protein	100µg	17641.8	ipatherapeutics
N001-0.5 mg	WNT Surrogate-Fc Fusion Protein	500µg	70270.2	ipatherapeutics
N001-1.0 mg	WNT Surrogate-Fc Fusion Protein	1mg	105454.8	ipatherapeutics
N002-100 ml	Noggin-Fc Fusion Protein Conditioned Medium	100ml	24690.6	ipatherapeutics
N002-200 ml	Noggin-Fc Fusion Protein Conditioned Medium	200ml	44569.8	ipatherapeutics
N002-500 ml	Noggin-Fc Fusion Protein Conditioned Medium	500ml	64548	ipatherapeutics
O001	OIT1, Murine	100ug	9603	ipatherapeutics
P001	Platelet Derived Growth Factor Βeta, Human	100ug	9999	ipatherapeutics
P002	PDGF-R Beta-(His)C, ECD, Human, Recombinant	100ug	10711.8	ipatherapeutics
R001-100 ml	Rspo3-Fc Fusion Protein Conditioned Medium	100ml	24690.6	ipatherapeutics
R001-200 ml	Rspo3-Fc Fusion Protein Conditioned Medium	200ml	44569.8	ipatherapeutics
R001-500 ml	Rspo3-Fc Fusion Protein Conditioned Medium	500ml	64548	ipatherapeutics
R002-0.1 mg	mRSPO1-Fc	0.1mg	9801	ipatherapeutics
R002-0.5 mg	mRSPO1-Fc	0.5mg	38966.4	ipatherapeutics
R002-1.0 mg	mRSPO1-Fc	1.0mg	58429.8	ipatherapeutics
R005-0.1 mg	mRSPO1-his	0.1mg	9801	ipatherapeutics
R005-0.5 mg	mRSPO1-his	0.5mg	38966.4	ipatherapeutics
R005-1.0 mg	mRSPO1-his	1.0mg	58429.8	ipatherapeutics
R006-0.1 mg	hRSPO1-Fc	0.1mg	9801	ipatherapeutics
R006-0.5 mg	hRSPO1-Fc	0.5mg	38966.4	ipatherapeutics
R006-1.0 mg	hRSPO1-Fc	1.0mg	58429.8	ipatherapeutics
R006-2.0 mg	hRSPO1-Fc	2.0mg	88723.8	ipatherapeutics
R007-0.1 mg	hRSPO1-his	0.1mg	9801	ipatherapeutics
R007-0.5 mg	hRSPO1-his	0.5mg	38966.4	ipatherapeutics
R007-1.0 mg	hRSPO1-his	1.0mg	58429.8	ipatherapeutics
R009-10 ml	enhanced Rspo3-Fc Fusion Protein Conditioned Medium	10ml	24472.8	ipatherapeutics
R009-50 ml	enhanced Rspo3-Fc Fusion Protein Conditioned Medium	50ml	97891.2	ipatherapeutics
R010-0.1 mg	enhanced Rspo3-Fc Fusion Protein	0.1mg	24472.8	ipatherapeutics
R010-0.5 mg	enhanced Rspo3-Fc Fusion Protein	0.5mg	97891.2	ipatherapeutics
S001	Sp-D, Porcine	100ug	9603	ipatherapeutics
S002	Sp-D, Human	100ug	9603	ipatherapeutics
S003A	Syndecan-1-(His)C, Human, Recombinant, higher glycosylation than S003B	100µg	10098	ipatherapeutics
S003B	Syndecan-1-(His)C, Human, Recombinant, lower glycosylation than S003A	100µg	10098	ipatherapeutics
T004	Tev Protease	1mg	18255.6	ipatherapeutics
T005	TFPI-Alpha-(His)C, Human, Recombinant	100µg	11226.6	ipatherapeutics
T006	Thrombomodulin-(Tev-His)N, Human, Recombinant	100µg	11226.6	ipatherapeutics
U001	Upar-(His)N, Human, Recombinant	100ug	10098	ipatherapeutics
V001	vWF-A1 Domain, Human, Residues 1261-1468	100ug	8375.4	ipatherapeutics
V002	vWF-A1 Domain, Human, Residues 1261-1468, VWD Type 2B, Recombinant	100ug	8989.2	ipatherapeutics
V003	vWF-A1 Domain, Human, Residues 1238-1481, Glycosylated	100ug	10711.8	ipatherapeutics
V004	vWF-A3 Domain, Human, Residues 1683-1874, Recombinant	100ug	9603	ipatherapeutics
V005	vWF-A3 Domain, Human, Residues 1683-1874, without Tag, Recombinant	100ug	10197	ipatherapeutics
V010	VCAM1-(His)N, Transcript A, Human, Recombinant	100ug	11226.6	ipatherapeutics
V011	vWF-A1-A2-A3-(his)C domain, Human, Residues 1261-1874, Recombinant	100µg	13068	ipatherapeutics
V012	vWF-A1-A2-A3-R1597Q-(his)C domain, Human, Residues 1261-1874, Recombinant	100µg	13068	ipatherapeutics
PODI-0005	mouse anti-barley LTP	100ug	8375.4	ipatherapeutics
PODI-0006	mouse anti-human ACTH (POMC)	100ug	8375.4	ipatherapeutics
PODI-0007	mouse anti-rabbit uteroglobuline	100ug	8375.4	ipatherapeutics
PODI-0008	mouse anti-Trichinella spiralis	100ug	8375.4	ipatherapeutics
PODI-0009	mouse anti-Leptospira interogans OMP (2D1D7)	100ug	8375.4	ipatherapeutics
PODI-0011	mouse anti-Cowdria ruminantium OMP (1E5H8)	100ug	8375.4	ipatherapeutics
PODI-0012	mouse anti-Cowdria ruminantium OMP (4F10B4)	100ug	8375.4	ipatherapeutics
PODI-0013	mouse anti-human HSP60, specific for eukaryotic HSP60	100ug	8375.4	ipatherapeutics
PODI-0014	mouse anti-human HSP60, specific for eukaryotic and prokaryotic HSP60	100ug	8375.4	ipatherapeutics
PODI-0015	mouse anti-HSP70, cross reactive with E.coli DNAK	100ug	8375.4	ipatherapeutics
PODI-0016	mouse anti-sheep IgE	100ug	8375.4	ipatherapeutics
PODI-0017	mouse anti-rat gonocytes	100ug	8375.4	ipatherapeutics
PODI-0018	mouse anti-chloroamphenicol	100ug	8375.4	ipatherapeutics
PODI-0019	mouse anti-human PLK1	100ug	8375.4	ipatherapeutics
PODI-0023	mouse anti-human PBDK1	100ug	8375.4	ipatherapeutics
PODI-0027	mouse anti-human PBDK2	100ug	8375.4	ipatherapeutics
PODI-0031	mouse anti-human Mps1	100ug	8375.4	ipatherapeutics
PODI-0034	mouse anti-GFP	100ug	8375.4	ipatherapeutics
PODI-0035	mouse anti-human MASP-2	100ug	8375.4	ipatherapeutics
PODI-0037	mouse anti-human FAM3D	100ug	8375.4	ipatherapeutics
PODI-0038	mouse anti-human FAM3D, cross reacts with mouse Oit-1	100ug	8375.4	ipatherapeutics
PODI-0039	mouse anti-human MBL-2	100ug	8375.4	ipatherapeutics
PODI-0040	human Placental Alkaline Phosphatase (2B4H11)	100ug	8375.4	ipatherapeutics
PODI-0042	human Placental Alkaline Phosphatase (23F4G3)	100ug	8375.4	ipatherapeutics
PODI-0043	human Intestinal Alkaline Phosphatase (8A8E3)	100ug	8375.4	ipatherapeutics
PODI-0058	mouse anti-rat CD40	100ug	8375.4	ipatherapeutics
PODI-0059	mouse anti-Ovalbumin	100ug	8375.4	ipatherapeutics
PODI-0061	mouse anti-Neisseria meningitidis Omp85 (32F9)	100ug	8375.4	ipatherapeutics
PODI-0063	mouse anti-Lactobacillus rhamnosus SpaC	100ug	8375.4	ipatherapeutics
PODI-0064	mouse anti-Streptococcus pneumonia PspA	100ug	8375.4	ipatherapeutics
PODI-0065	mouse anti-human PDGF	100ug	8375.4	ipatherapeutics
PODI-0068	mouse anti-human CD36, cross reacts with dog	100ug	8375.4	ipatherapeutics
PODI-0069	mouse anti-STREP-II tag	100ug	8375.4	ipatherapeutics
PODI-0070	mouse anti-human Mart-1, IHC on melanoma tissue	100ug	8375.4	ipatherapeutics
PODI-0071	mouse anti-human BCHE	100ug	8375.4	ipatherapeutics
PODI-0073	mouse anti-human IGFBP-7	100ug	8375.4	ipatherapeutics
PODI-0076	mouse anti-Neisseria meningitidis Omp85	100ug	8375.4	ipatherapeutics
PODI-0077	mouse anti-N-terminal-His tag	100ug	8375.4	ipatherapeutics
PODI-0079	human Intestinal Alkaline Phosphatase, detector antibody in ELISA with 8A8E3	100ug	8375.4	ipatherapeutics
PODI-0080	mouse anti-human Factor V	100ug	8375.4	ipatherapeutics
PODI-0081	mouse anti-human PKM2	100ug	8375.4	ipatherapeutics
PODI-0082	mouse anti-human CD63	100ug	8375.4	ipatherapeutics
PODI-0083	mouse anti-human CD31	100ug	8375.4	ipatherapeutics
PODI-0084	mouse anti-human CD41	100ug	8375.4	ipatherapeutics
PODI-0085	mouse anti-human CD61	100ug	8375.4	ipatherapeutics
PODI-0086	mouse anti-human CD42B	100ug	8375.4	ipatherapeutics
PODI-0087	mouse anti-human vWF	100ug	8375.4	ipatherapeutics
PODI-0088	mouse anti-Thrombospondin	100ug	8375.4	ipatherapeutics
PODI-0089	mouse anti-Annexin-5	100ug	8375.4	ipatherapeutics
PODI-0090	mouse anti-human Protein S	100ug	8375.4	ipatherapeutics
PODI-0091	mouse anti-CD40 (8B9)	100ug	8375.4	ipatherapeutics
PODI-0092	mouse anti-CD40 (16B4E4)	100ug	8375.4	ipatherapeutics
PODI-0093	mouse anti-NY-ESO	100ug	8375.4	ipatherapeutics

文件下載

上一篇：Immunoguide 2026年終端采購售價(jià)清單-上海起發(fā)
下一篇：bostonbioproducts 2026年終端采購售價(jià)清單-上海起發(fā)